AP607A - Inhibiting photodecomposition of 3-substituted-2-oxindoles. - Google Patents
Inhibiting photodecomposition of 3-substituted-2-oxindoles. Download PDFInfo
- Publication number
- AP607A AP607A APAP/P/1996/000787A AP9600787A AP607A AP 607 A AP607 A AP 607A AP 9600787 A AP9600787 A AP 9600787A AP 607 A AP607 A AP 607A
- Authority
- AP
- ARIPO
- Prior art keywords
- red
- yellow
- dye
- lake
- thienyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Polymerisation Methods In General (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB1995/000287 WO1996033701A1 (en) | 1995-04-24 | 1995-04-24 | Inhibiting photodecomposition of 3-substituted-2-oxindoles |
Publications (2)
Publication Number | Publication Date |
---|---|
AP9600787A0 AP9600787A0 (en) | 1996-04-30 |
AP607A true AP607A (en) | 1997-08-27 |
Family
ID=36997502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
APAP/P/1996/000787A AP607A (en) | 1995-04-24 | 1996-03-07 | Inhibiting photodecomposition of 3-substituted-2-oxindoles. |
Country Status (30)
Country | Link |
---|---|
EP (1) | EP0827399A1 (sv) |
JP (1) | JPH10506635A (sv) |
KR (1) | KR100189585B1 (sv) |
CN (1) | CN1053667C (sv) |
AP (1) | AP607A (sv) |
AR (1) | AR002728A1 (sv) |
AU (1) | AU692378B2 (sv) |
BG (1) | BG100531A (sv) |
BR (1) | BR9602024A (sv) |
CO (1) | CO4700418A1 (sv) |
FI (1) | FI973988A0 (sv) |
HR (1) | HRP960194A2 (sv) |
HU (1) | HU216544B (sv) |
IL (1) | IL117969A0 (sv) |
IS (1) | IS4339A (sv) |
MA (1) | MA23848A1 (sv) |
NO (1) | NO961622L (sv) |
NZ (1) | NZ286432A (sv) |
OA (1) | OA10286A (sv) |
PE (1) | PE34397A1 (sv) |
RO (1) | RO113305B1 (sv) |
RU (1) | RU2109510C1 (sv) |
SG (1) | SG64924A1 (sv) |
SI (1) | SI9600133A (sv) |
SK (1) | SK51296A3 (sv) |
TR (1) | TR199600300A2 (sv) |
UA (1) | UA42739C2 (sv) |
WO (1) | WO1996033701A1 (sv) |
YU (1) | YU25096A (sv) |
ZA (1) | ZA963210B (sv) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111526730B (zh) | 2017-12-29 | 2024-02-23 | 卡夫食品集团品牌有限责任公司 | 使用天然稳定剂改善的水包油乳液的氧化稳定性 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2246072A (en) * | 1990-07-20 | 1992-01-22 | Egyt Gyogyszervegyeszeti Gyar | Pharmaceutical compositions stabilised against light |
WO1994007488A1 (en) * | 1992-10-07 | 1994-04-14 | Pfizer Inc. | 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions |
-
1995
- 1995-04-24 WO PCT/IB1995/000287 patent/WO1996033701A1/en not_active Application Discontinuation
- 1995-04-24 EP EP95914494A patent/EP0827399A1/en not_active Ceased
- 1995-04-24 RU RU96108120A patent/RU2109510C1/ru active
- 1995-04-24 UA UA96041574A patent/UA42739C2/uk unknown
- 1995-04-24 JP JP8532298A patent/JPH10506635A/ja active Pending
- 1995-04-24 SK SK512-96A patent/SK51296A3/sk unknown
-
1996
- 1996-03-07 AP APAP/P/1996/000787A patent/AP607A/en active
- 1996-03-28 AR ARP960101956A patent/AR002728A1/es unknown
- 1996-04-10 TR TR96/00300A patent/TR199600300A2/xx unknown
- 1996-04-18 IL IL11796996A patent/IL117969A0/xx unknown
- 1996-04-19 SG SG1996009306A patent/SG64924A1/en unknown
- 1996-04-19 IS IS4339A patent/IS4339A/is unknown
- 1996-04-22 PE PE1996000275A patent/PE34397A1/es not_active Application Discontinuation
- 1996-04-22 CN CN96105084A patent/CN1053667C/zh not_active Expired - Fee Related
- 1996-04-22 RO RO96-00843A patent/RO113305B1/ro unknown
- 1996-04-22 CO CO96019210A patent/CO4700418A1/es unknown
- 1996-04-23 NZ NZ286432A patent/NZ286432A/en unknown
- 1996-04-23 KR KR1019960012356A patent/KR100189585B1/ko not_active IP Right Cessation
- 1996-04-23 HR HRPCT/IB95/00287A patent/HRP960194A2/hr not_active Application Discontinuation
- 1996-04-23 HU HU9601057A patent/HU216544B/hu not_active IP Right Cessation
- 1996-04-23 YU YU25096A patent/YU25096A/sh unknown
- 1996-04-23 BG BG100531A patent/BG100531A/xx unknown
- 1996-04-23 NO NO961622A patent/NO961622L/no unknown
- 1996-04-23 AU AU50851/96A patent/AU692378B2/en not_active Ceased
- 1996-04-23 ZA ZA9603210A patent/ZA963210B/xx unknown
- 1996-04-23 MA MA24209A patent/MA23848A1/fr unknown
- 1996-04-24 SI SI9600133A patent/SI9600133A/sl not_active IP Right Cessation
- 1996-04-24 OA OA60821A patent/OA10286A/en unknown
- 1996-04-24 BR BR9602024A patent/BR9602024A/pt active Search and Examination
-
1997
- 1997-10-17 FI FI973988A patent/FI973988A0/sv unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2246072A (en) * | 1990-07-20 | 1992-01-22 | Egyt Gyogyszervegyeszeti Gyar | Pharmaceutical compositions stabilised against light |
WO1994007488A1 (en) * | 1992-10-07 | 1994-04-14 | Pfizer Inc. | 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1303504C (en) | Pharmaceutical formulation containing acrivastine | |
RU2140782C1 (ru) | Улучшенные фармацевтические препараты, содержащие ибупрофен и кодеин | |
CA2501587C (en) | Solid preparation having phase containing insulin sensitizer and another active ingredient uniformly mixed | |
HRP20192026T1 (hr) | Formulacija tableta od neratinib maleata | |
NZ270748A (en) | Sustained release dosage form of alfuzosin hydrochloride coated with a ph-dissolution dependent polymer | |
ATE195073T1 (de) | Feste pharmazeutische zubereitung mit (s)-2-(4- isobutylphenyl)propionsäure als wirkstoff und mikrokristalliner cellulose und kolloidalem silica als hilfstoff | |
CA1300509C (en) | Pharmaceutical compositions for relief of dysmenorrhea and/orpremenstrual syndrome and process | |
KR20100012105A (ko) | 인슐린 감작제, 인슐린 분비촉진제 및 폴리옥시에틸렌 소르비탄 지방산 에스테르를 함유하는 고체 제제 | |
AP607A (en) | Inhibiting photodecomposition of 3-substituted-2-oxindoles. | |
CA1069441A (en) | Pharmaceutical composition containing 2,1,3-benzothiazole | |
CA2003478A1 (en) | Combination of an hmg coa reductase inhibitor and other type of serum cholesterol reducing agent and method for lowering serum cholesterol using such combination | |
CA2216931A1 (en) | Inhibiting photodecomposition of 3-substituted-2-oxindoles | |
NL8002041A (nl) | Werkwijze voor het bereiden van een analgetisch en myotonolytisch geneesmiddel. | |
US4188393A (en) | Treating spastic conditions or relaxing muscles | |
TW577741B (en) | Novel pharmaceutical combination for treating pain comprising paracetamol and buspirone | |
EP0444546B1 (en) | Hydantoin derivatives for use as hypoglycemic and/or hypolipidemic agents | |
US4333945A (en) | Thiazoline and imidazoline derivatives useful as minor tranquilizers | |
AU620658B2 (en) | Memory-enhancing compositions containing dioxopiperidine derivatives | |
MXPA97008155A (en) | Inhibition of the photo-composition of 2-oxindoles 3-substitute | |
MXPA00004573A (en) | Novel oral dosage form for carvedilol |